Evaluation and use of surveillance system data toward the identification of high-risk areas for potential cholera vaccination: a case study from Niger
详细信息 查看全文
- 作者：Jose Guerra (1)
Bachir Mayana (2)
Ali Djibo (3)
Mahamane L Manzo (2)
Augusto E Llosa (1)
Rebecca F Grais (1) - 刊名：BMC Research Notes
- 出版年：2012
- 出版时间：December 2012
- 年：2012
- 卷：5
- 期：1
- 全文大小：326KB
- 参考文献：1. Cholera: global surveillance summary, 2008 / Wkly Epidemiol Rec 2009, 84:309-24.
2. Global Task Force on Cholera Control: / Cholera country profile. World Health Organization, Niger; 2010. ef="http://www.who.int/cholera/countries/NigerCountryProfile2010.pdf" class="a-plus-plus">http://www.who.int/cholera/countries/NigerCountryProfile2010.pdf
3. Clemens JD, Sack DA, Harris JR, Chakraborty J, Khan MR, Stanton BF, Ali M, Ahmed F, Yunus M, Kay BA: Impact of B subunit killed whole-cell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera. / Lancet 1988, 1:1375-379. external" href="http://dx.doi.org/10.1016/S0140-6736(88)92189-7">CrossRef
4. Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD: Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. / Lancet 2009, 374:1694-702. external" href="http://dx.doi.org/10.1016/S0140-6736(09)61297-6">CrossRef
5. Sinclair D, Abba K, Zaman K, Qadri F, Graves PM: Oral vaccines for preventing cholera. / Cochrane Database Syst Rev 2011, --- CD008603
6. Ali M, Emch M, von Seidlein L, Yunus M, Sack DA, Rao M, Holmgren J, Clemens JD: Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. / Lancet 2005, 366:44-9. external" href="http://dx.doi.org/10.1016/S0140-6736(05)66550-6">CrossRef
7. Longini IM, Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD: Controlling endemic cholera with oral vaccines. / PLoS Med 2007, 4:e336. external" href="http://dx.doi.org/10.1371/journal.pmed.0040336">CrossRef
8. Meeting of the Strategic advisory Group of Experts on immunization: October 2009 -conclusions and recommendations. / Wkly Epidemiol Rec 2009, 84:517-32.
9. Enserink M: Public health. No vaccines in the time of cholera. / Science 2010, 329:1462-463. external" href="http://dx.doi.org/10.1126/science.329.5998.1462">CrossRef
10. Guidelines Working Group: / Updated Guidelines for Evaluating Public Health Surveillance Systems. CDC. 2001. ef="http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm" class="a-plus-plus">http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm
11. R development Core Team: / R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2010.
12. World Health Organization Regional Office for Africa and the Centers for Disease Control and Prevention: / Technical Guidelines for Integrated Disease Surveillance and Response in the African Region. Harare, Zimbabwe and Atlanta, Georgia, USA; 2001. ef="http://www.cdc.gov/idsr/focus/surv_sys_strengthening/tech_guidelines-integrated-diseaseENG.pdf" class="a-plus-plus">http://www.cdc.gov/idsr/focus/surv_sys_strengthening/tech_guidelines-integrated-diseaseENG.pdf
13. Guerra J: / Evaluation du système de surveillance du choléra dans la région de Maradi. Epicentre. 2010. ef="http://www.clisp.fr/references/SurvCholMaradi.pdf" class="a-plus-plus">http://www.clisp.fr/references/SurvCholMaradi.pdf
14. République du Niger: Ministère de la Santé Publique et de la Lutte contre les Endémies. / Plan de Développement Sanitaire 2005-009 2005.
15. Sack DA: When should cholera vaccine be used in cholera-endemic areas? / J Health Popul Nutr 2003, 21:299-03.
16. Glass RI, Becker S, Huq MI, Stoll BJ, Khan MU, Merson MH, Lee JV, Black RE: Endemic cholera in rural Bangladesh, 1966-980. / Am J Epidemiol 1982, 116:959-70.
17. Deen JL, von Seidlein L, Sur D, Agtini M, Lucas MES, Lopez AL, Kim DR, Ali M, Clemens JD: The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. / PLoS Negl Trop Dis 2008,2(2):e173. external" href="http://dx.doi.org/10.1371/journal.pntd.0000173">CrossRef
18. Cholera vaccines: WHO position paper / Wkly Epidemiol Rec 2010, 85:117-28.
19. Jeuland M, Cook J, Poulos C, Clemens J, Whittington D: Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis. / Value Health 2009, 12:899-08. external" href="http://dx.doi.org/10.1111/j.1524-4733.2009.00562.x">CrossRef - 作者单位：Jose Guerra (1)
Bachir Mayana (2)
Ali Djibo (3)
Mahamane L Manzo (2)
Augusto E Llosa (1)
Rebecca F Grais (1)
1. Epicentre, 8, rue St-Sabin, 75011, Paris, France
2. Direction régionale de la Santé Publique, Maradi, Niger
3. Faculté des sciences de la santé, Université de Niamey, Niamey, Niger
文摘
Background In 2008, Africa accounted for 94% of the cholera cases reported worldwide. Although the World Health Organization currently recommends the oral cholera vaccine in endemic areas for high-risk populations, its use in Sub-Saharan Africa has been limited. Here, we provide the principal results of an evaluation of the cholera surveillance system in the region of Maradi in Niger and an analysis of its data towards identifying high-risk areas for cholera. Results We evaluated the cholera surveillance data using a standard CDC protocol, through interviews with heads of the system, and a review of cholera data collected between 2006-009. The surveillance system was found to be sufficiently reliable to be able to utilize the data for the detection of high risk areas for cholera vaccination. Temporal, geographic and socio-demographic analyses of cholera cases indicated that between 2006 and 2009, 433 cholera cases were reported in the Maradi region of Niger. Two deprived neighborhoods of the region’s capital city, Bagalam and Yandaka, represented 1% of the regional population and 21% of the cholera cases, reaching a yearly incidence rate of 3 per 1000 in 2006 and 2008, respectively. Conclusions The results of this evaluation suggest that the reporting sensitivity of the surveillance system is sufficient, to appropriately classify the region as cholera endemic. Additionally, two overcrowded neighborhoods in the regional capital met WHO criteria for consideration for cholera vaccination.